Nutriomics Logo Nutriomics Retina Logo
  • Home
  • Research
    • WP1 / Progression of obesity and related complications: role of gut microbiota?
    • WP2 / Intestine as a key player in metabolic disorders
    • WP3 / Adipose tissue Remodeling
    • WP4 / Systems’ biology and data integration (transversal WP)
    • WP5 / Translating our fundamental research for the benefit of patients
  • Team
    • Members
    • Workflow
    • History
  • Collabs
  • Cohorts
  • Tools
  • Publications
  • Contact
  • Home
  • Research
    • WP1 / Progression of obesity and related complications: role of gut microbiota?
    • WP2 / Intestine as a key player in metabolic disorders
    • WP3 / Adipose tissue Remodeling
    • WP4 / Systems’ biology and data integration (transversal WP)
    • WP5 / Translating our fundamental research for the benefit of patients
  • Team
    • Members
    • Workflow
    • History
  • Collabs
  • Cohorts
  • Tools
  • Publications
  • Contact

Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist

Home/Posts/Publications/Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
Previous Next
Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist

Authors: Kühnen P, Clément K, Wiegand S, Blankenstein O, Gottesdiener K, Martini LL, Mai K, Blume-Peytavi U, Grüters A, Krude H
N. Engl. J. Med. 2016 Jul;375(3):240-6
PubMed ID: 27468060

Abstract

Patients with rare defects in the gene encoding proopiomelanocortin (POMC) have extreme early-onset obesity, hyperphagia, hypopigmentation, and hypocortisolism, resulting from the lack of the proopiomelanocortin-derived peptides melanocyte-stimulating hormone and corticotropin. In such patients, adrenal insufficiency must be treated with hydrocortisone early in life. No effective pharmacologic treatments have been available for the hyperphagia and obesity that characterize the condition. In this investigator-initiated, open-label study, two patients with proopiomelanocortin deficiency were treated with setmelanotide, a new melanocortin-4 receptor agonist. The patients had a sustainable reduction in hunger and substantial weight loss (51.0 kg after 42 weeks in Patient 1 and 20.5 kg after 12 weeks in Patient 2).

By Kühnen P, Clément K, Wiegand S, Blankenstein O, Gottesdiener K, Martini LL, Mai K, Blume-Peytavi U, Grüters A, Krude H| 2017-10-05T23:40:57+00:00 July 29, 2016|

Share This Story, Choose Your Platform!

FacebookTwitterLinkedinRedditTumblrGoogle+PinterestVkEmail

Related Posts

  • Gut microbiota and obesity: Concepts relevant to clinical care

    Gut microbiota and obesity: Concepts relevant to clinical care

    March 8, 2018
  • The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass

    The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass

    July 22, 2017
  • Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue

    Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue

    June 8, 2017
  • The FAT Score, a Fibrosis Score of Adipose Tissue: Predicting Weight-Loss Outcome After Gastric Bypass

    The FAT Score, a Fibrosis Score of Adipose Tissue: Predicting Weight-Loss Outcome After Gastric Bypass

    April 18, 2017
  • Prospective assessment and histological analysis of adherent perinephric fat in partial nephrectomies

    Prospective assessment and histological analysis of adherent perinephric fat in partial nephrectomies

    March 25, 2017
  • Knee and hip intra-articular adipose tissues (IAATs) compared with autologous subcutaneous adipose tissue: a specific phenotype for a central player in osteoarthritis

    Knee and hip intra-articular adipose tissues (IAATs) compared with autologous subcutaneous adipose tissue: a specific phenotype for a central player in osteoarthritis

    March 16, 2017
  • Popular
  • Recent
  • The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass
    July 22, 2017
  • Prospective assessment and histological analysis of adherent perinephric fat in partial nephrectomies
    March 25, 2017
  • The FAT Score, a Fibrosis Score of Adipose Tissue: Predicting Weight-Loss Outcome After Gastric Bypass
    April 18, 2017
  • Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance
    August 18, 2018
  • Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes
    July 18, 2018
  • Gut microbiota and obesity: Concepts relevant to clinical care
    March 8, 2018

Recent Posts

  • Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance
  • Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes
  • Gut microbiota and obesity: Concepts relevant to clinical care
  • The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass
  • Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue

Archives

  • Home
  • Research
  • Team
  • Publications
  • Cohorts
  • Tools
  • Contact & Plan
Copyright 2012 - 2017 Nutriomics | All Rights Reserved